These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34022386)

  • 1. Dupilumab in the treatment of nasal polyposis: A retrospective, real-world study.
    Nowsheen S; Darveaux JI
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):386-387. PubMed ID: 34022386
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
    Laidlaw TM; Bachert C; Amin N; Desrosiers M; Hellings PW; Mullol J; Maspero JF; Gevaert P; Zhang M; Mao X; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    Ann Allergy Asthma Immunol; 2021 May; 126(5):584-592.e1. PubMed ID: 33465455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis.
    Aschenbrenner DS
    Am J Nurs; 2019 Oct; 119(10):21-22. PubMed ID: 31567245
    [No Abstract]   [Full Text] [Related]  

  • 4. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Boyle JV; Lam K; Han JK
    Immunotherapy; 2020 Feb; 12(2):111-121. PubMed ID: 32075470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctivitis in dupilumab clinical trials.
    Akinlade B; Guttman-Yassky E; de Bruin-Weller M; Simpson EL; Blauvelt A; Cork MJ; Prens E; Asbell P; Akpek E; Corren J; Bachert C; Hirano I; Weyne J; Korotzer A; Chen Z; Hultsch T; Zhu X; Davis JD; Mannent L; Hamilton JD; Teper A; Staudinger H; Rizova E; Pirozzi G; Graham NMH; Shumel B; Ardeleanu M; Wollenberg A
    Br J Dermatol; 2019 Sep; 181(3):459-473. PubMed ID: 30851191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
    Bachert C; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Joish VN; Chao J; Mannent LP; Amin N; Abbe A; Taniou C; Fan C; Pirozzi G; Graham NMH; Mahajan P; Staudinger H; Khan A
    Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients.
    Calugareanu A; Jachiet M; Tauber M; Nosbaum A; Aubin F; Misery L; Droitcourt C; Barbarot S; Debarbieux S; Saussine A; Bagot M; de Masson A; Sénéschal J; Staumont-Sallé D; Bouaziz JD;
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e74-e76. PubMed ID: 31529718
    [No Abstract]   [Full Text] [Related]  

  • 10. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab: short-term effectiveness and security in real clinical practice - A retrospective multicentric study.
    Ruiz-Villaverde R; Dominguez-Cruz J; Armario-Hita JC; Martinez-Pilar L; Alcantara-Luna S; Pereyra-Rodriguez JJ
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):e21-e22. PubMed ID: 29888527
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of Dupilumab.
    Harb H; Chatila TA
    Clin Exp Allergy; 2020 Jan; 50(1):5-14. PubMed ID: 31505066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis.
    Lipworth B; Chan R; Kuo CR
    J Allergy Clin Immunol; 2021 Jan; 147(1):413. PubMed ID: 33160644
    [No Abstract]   [Full Text] [Related]  

  • 14. Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis.
    Jonstam K; Swanson BN; Mannent LP; Cardell LO; Tian N; Wang Y; Zhang D; Fan C; Holtappels G; Hamilton JD; Grabher A; Graham NMH; Pirozzi G; Bachert C
    Allergy; 2019 Apr; 74(4):743-752. PubMed ID: 30488542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis.
    Cavaliere C; Masieri S; Greco A; Lambiase A; Segatto M
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):442-443. PubMed ID: 33465456
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis.
    Sposato B; Scalese M; Camiciottoli G; Carpagnano GE; Pelaia C; Santus P; Maniscalco M; Corsico A; Grosso A; Baglioni S; Murgia N; Folletti I; Pelaia G; Masieri S; Cavaliere C; Musarra A; Bargagli E; Ricci A; Latorre M; Rogliani P; Paggiaro P
    Respir Med Res; 2020 Nov; 78():100791. PubMed ID: 33039948
    [No Abstract]   [Full Text] [Related]  

  • 18. Respiratory epithelial adenomatoid hamartoma with nasal polyps affects dupilumab efficacy.
    Takeda T; Yanagi N; Fukasawa N; Mori E; Maeda M; Sakaguchi R; Tei M; Omura K; Otori N
    Rhinology; 2022 Apr; 60(2):148-151. PubMed ID: 35174813
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of Sézary syndrome following the administration of dupilumab.
    Tran J; Morris L; Vu A; Duvic M
    Dermatol Online J; 2020 Apr; 26(4):. PubMed ID: 32621690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
    Liberman P; Shifera AS; Berkenstock M
    Cornea; 2020 Jun; 39(6):784-786. PubMed ID: 31985517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.